Curidium Medica plc

Bringing the right medicine to the right patientThrough understanding the biological, genetic and environmental causes of disease, Curidium believes future drug development will be targeted to more accurately defined subgroups of patients who will benefit from focused drug therapies.
This approach has been successfully applied in the areas of cardiovascular and cancer therapeutics. Herceptin®, which is prescribed to patients testing positive for the molecular diagnostic HercepTest™ is an example of this approach in breast cancer.
Curidium is a drug discovery business that is advancing this new wave of disease management by using targeted and personalised medicines for the treatment of Central Nervous System (CNS) disorders. Disease diagnosis in this sector is largely based on clinical signs and symptoms. However, through its proprietary technology, Homomatrix®, diagnosis can be made at the biological level, thus potentially allowing much more accurate and successful therapy.

Contact Details: Hamilton House, Mabledon Place, London London WC1H 9BB United Kingdom Tel: 44 (0)20 7554 8790 Fax: 44 (0)20 7554 8791 Email: info@curidium.com WWW: www.curidium.com/

Loading...

Contact BioPortfolio for a quote for a customised Excel verision of BioCorporate or BioEmail databases.

This page has been viewed 253 times since April 2007, the link to the organisation's website has been followed 39 times

Search for more companies in London

Search for more companies in London

This site uses Thumbshots previews, resources from the NCBI applied. Maps are centred on zip/postcodes and should not be relied upon for exact building locations. Some information on this page has been collected automatically and may not have been verified.
BioPortfolio search results for Curidium Medica plc